Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Prenetics Group (PRE) Stock Price & Analysis

91 Followers

PRE Stock Chart & Stats

$16.51-$0.21(-1.26%)
At close: 4:00 PM EST
$17.5$20$22.5$25Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$16.30 - $17.74
52-Week Range
$11.37 - $27.24
Previous Close
$16.72
Volume
N/A
Average Volume (3M)
192.00K
Market Cap
$283.20M
Enterprise Value
$221.33M
Total Cash (Recent Filing)
$109.39M
Total Debt (Recent Filing)
$682.00K
Price to Earnings (P/E)
―
Beta
0.47
Next Earnings
Nov 18, 2026 (Est.)
EPS Estimate
-0.82
Last Dividend Ex-Date
Feb 17, 2016
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Accelerating Revenue Growth

Rapid revenue expansion, higher guidance, and a stated 2027 target above $400M indicate that Prenetics is scaling beyond an early proof of concept. If execution continues, greater volume can broaden customer reach, improve operating leverage, and strengthen the company’s position in consumer health.

Recurring Subscribers And Improving Unit Economics

A high recurring-revenue mix and a growing subscriber base can make demand more predictable than one-time test sales. Improving customer acquisition costs and reported gross-profit returns also suggest that marketing efficiency is strengthening, supporting scalable growth if retention remains durable.

Strong Margins And Operating Leverage

The combination of 65% gross margin and 46% contribution margin provides meaningful economic value before corporate costs. Falling fixed expenses and lower operating costs as a share of sales could allow incremental revenue to convert more efficiently into earnings as the platform matures.

Bears Say

Persistent Net And Operating Losses

Prenetics is growing quickly but has not yet demonstrated sustainable profitability. Large net and operating losses mean the business still needs substantial improvement in cost absorption and marketing efficiency, leaving earnings vulnerable if growth slows or acquisition spending remains elevated.

Ongoing Cash Burn

Repeated negative operating and free cash flow indicate that reported growth has not consistently translated into internally generated funding. Continued cash burn can reduce financial flexibility and require reliance on liquidity or external capital before the operating model reaches self-sustaining cash generation.

Financing And Cohort-Maturity Dependence

The growth model depends partly on external financing and on early cohort performance that has not fully matured. If retention or customer economics weaken as cohorts age, the expected returns from acquisition spending could fall, making expansion more costly and increasing funding dependence.

Prenetics Group News

PRE FAQ

What was Prenetics Group’s price range in the past 12 months?
Prenetics Group lowest stock price was $11.37 and its highest was $27.24 in the past 12 months.
What is Prenetics Group’s market cap?
Prenetics Group’s market cap is $283.20M.
When is Prenetics Group’s upcoming earnings report date?
Prenetics Group’s next earnings report is estimated for Nov 18, 2026 (not yet confirmed), which is in 4 days.
How were Prenetics Group’s earnings last quarter?
Prenetics Group released its earnings results on Aug 18, 2026. The company reported -$0.53 earnings per share for the quarter, beating the consensus estimate of -$0.84 by $0.31.
Is Prenetics Group overvalued?
According to Wall Street analysts Prenetics Group’s price is currently Undervalued.
Does Prenetics Group pay dividends?
Prenetics Group pays a quarterly dividend of $0.7 which represents an annual dividend yield of ―. See more information on Prenetics Group dividends here
What is Prenetics Group’s EPS estimate?
Prenetics Group’s EPS estimate is -0.82.
How many shares outstanding does Prenetics Group have?
Prenetics Group has 15,356,748 shares outstanding.
What happened to Prenetics Group’s price movement after its last earnings report?
Prenetics Group reported an EPS of -$0.53 in its last earnings report, beating expectations of -$0.84. Following the earnings report the stock price went up 0.155%.
Which hedge fund is a major shareholder of Prenetics Group?
Hedge funds hold Prenetics Group shares: the largest hedge-fund position in Prenetics Group is 70,122,713 shares, and hedge funds decreased their holdings by 21.2K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology